Low ARID1A expression has been linked with poor outcome and platinum resistance in HGSOC (Yokoyama et al., 2014) and clear-cell ovarian cancers (Itamochi et al., 2015; Katagiri et al., 2012). Here, ARID1A is linked to ovarian clear cell cancer.